August 18, 2006
For Immediate Release
Ablation and Other Energy-Based Devices in General Surgery (MedMarkets)
FOOTHILL RANCH, CA — The dynamic market for energy-based devices used in general surgery is growing steadily with compounded annual growth rates of 12% projected for the 2003–2008 period, according to the August 2006 issue of MedMarkets from MedMarket Diligence.
This market includes devices based on ultrasonic, radio frequency (RF), light, thermal, hydromechanical, cryogenic and microwave technologies. Among these, ultrasonic devices hold the lion’s share of the general surgery market at 60% The second largest segment in the market for energy-based devices used in general surgery comprises devices based on RF energy, which (like laser systems) rely on thermal welding to achieve tissue coagulation. RF devices comprise roughly 27% of the overall market for devices used in general surgery.
The August 2006 issue of MedMarkets further explores the technologies and general surgery applications of the range of ablation technologies on the market and in development, and details company activities. While acquisitions have characterized the market of late, innovations are also part of current market developments.
MedMarkets is published 12 times annually by MedMarket Diligence. Coverage encompasses medical device, biotech, biomaterials and the range of technologies encompassing device market developments and analysis of Interventional Cardiology, Cardiovascular Surgery, Orthopedics/Musculoskeletal, Abdominal & Thoracic Surgery, Gynecology, Oncology, Neurology & Neurosurgery and other clinical sectors. Past coverage may be reviewed at www.mediligence.com/archive2006.html.
MedMarket Diligence provides tactical decision-making solutions on medical
technology to the medical products and investment industries. The company
MedMarkets newsletter, a monthly analysis of the market implications of new
medical technologies, and dedicated reports on technology markets. For
additional details, contact Patrick Driscoll at
email or call
949-859-3401 or toll-free (in the U.S.). 1-866-820-1357.